WASHINGTON INSTITUTE FOR COAGULATION (EIN 832302258) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

EVA SZYSZKA

Phone

2066141200

Tax Period

2024-07-01 to 2025-06-30

WASHINGTON INSTITUTE FOR COAGULATION, founded in 2018, is a major nonprofit in the Diseases & Disorders sector that reported $112.7M in total revenue in fiscal year 2024. Revenue decreased 8% compared to the prior year. Expenses of $101.7M left a modest 10% surplus.

Mission

THE WASHINGTON CENTER FOR BLEEDING DISORDERS IS DEDICATED TO ASSURING OPTIMAL HEALTH FOR PEOPLE WITH BLEEDING DISORDERS THROUGH COMPREHENSIVE CARE, EDUCATION, AND RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $87,876

Program Service Revenue $110,795,343

Investment Income $1,769,155

Other Revenue $22,983

TOTAL REVENUE $112,675,357

Expense Breakdown

Grants Paid $0

Salaries & Benefits $6,965,567

Fundraising Expenses $0

Program Expenses $99,185,361

Other Expenses $94,728,767

TOTAL EXPENSES $101,694,334

Year-over-Year Comparison

	2024	2023	Change
Revenue	$112,675,357	$122,490,634	-0.1%
Expenses	$101,694,334	$108,898,367	-0.1%
Net Income	$10,981,023	$13,592,267	-0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$614,414

Total Directors

$576,344

Key Employees

$206,053

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
REBECCA KRUSE-JARRES MD	EXECUTIVE/MEDICAL DIRECTOR	40.00	Officer Director	$297,961	$70,987	$368,948
NEIL JOSEPHSON MD	PRESIDENT	1.00	Officer Director	$0	$0	$0
KRISHNA JAFA	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
KRISTIAN PRILL HAMILTON	BOARD MEMBER	1.00	Director	$0	$0	$0
ROSHNI KULKARNI	BOARD MEMBER	1.00	Director	$0	$0	$0
LORI JACOBSEN-TEWS	BOARD MEMBER	1.00	Director	$0	$0	$0
SETHU MEIYAPPAN	BOARD MEMBER	1.00	Director	$0	$0	$0
KIM SNYDER	CFO/COO (THRU 11/24)/BOARD TREASURER	40.00	Officer Director	$183,716	$23,680	$207,396
EVA SZYSZKA	CFO/COO	40.00	Officer	$36,525	$1,545	$38,070
HSIN KAI A CHEN	PHARMACY DIRECTOR	40.00	Key Emp	$174,064	$31,989	$206,053
JENNIFER LAMHARZI	CLINICAL NURSE MANAGER	40.00	Highest	$150,207	$32,465	$182,672
HEEBEEN KIM	CLINICAL PHARMACIST	40.00	Highest	$155,485	$20,312	$175,797
ANNE JEZZAMINE CHOI	NURSE PRACTITIONER	40.00	Highest	$141,912	$27,962	$169,874
AMY HARRIS	CONTROLLER	40.00	Highest	$145,335	$15,632	$160,967
KHOA LE	CLINICAL PHARMACIST	40.00	Highest	$141,860	$11,634	$153,494

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$112,675,357	$101,694,334	$87,751,207	$10,981,023
2024	No data	No data	No data	No data
2023	$114,481,287	$104,365,786	$74,267,913	$10,115,501
2022	$53,405,497	$49,511,083	$62,927,219	$3,894,414
2021	$104,303,330	$95,835,264	$62,548,021	$8,468,066
2020	$23,307,124	$5,320,012	$22,969,975	$17,987,112

WASHINGTON INSTITUTE FOR COAGULATION